Information Provided By:
Fly News Breaks for March 23, 2015
GNW
Mar 23, 2015 | 09:00 EDT
As previously reported, Raymond James upgraded Genworth to Strong Buy from Outperform. The firm upgraded shares based on valuation and sees several ways for value creation that include a breakup of the company. In addition, Genworth is a free option on the success of Biogen's (BIIB) BIIB037 Alzheimer's drug, as approximately 50% of long-term care insurance claims payments are for ALzheimer's or other form of dementia. Price target is $12.
News For GNW From the Last 2 Days
There are no results for your query GNW